Edition 5 / September 2019
For many pharma companies, the investment, facilities, equipment, process controls and challenges associated with meeting the new corresponding manufacturing requirements are still not fully understood, and can be therefore quite burdensome. Identifying and engaging established, competent and experienced external providers such as a global CDMO is an excellent alternative.
This webinar will introduce the topic of combination device & drug products, provide an overview of the regulatory landscape with a particular focus on injectable drugs led by Mark Chipperfield of Corvus Device Ltd., and highlight how CordenPharma’s Injectable Platform is uniquely placed to help pharma companies.
As a participant, you will:
Additionally you will get a thorough picture of CordenPharma’s injectable manufacturing capability to consistently support Aseptic Fill & Finish, as well as terminally sterilized drug products, by looking to recent investments and projected areas of growth for our injectable portfolio and capabilities.
Stay up to date with the latest thought leadership articles and news from CordenPharma.